Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04256317
Title A Study of ASTX030 (Cedazuridine in Combination With Azacitidine) in MDS, CMML, or AML
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Astex Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
John Theurer Cancer Center / Hackensack University RECRUITING Hackensack New Jersey 07601 United States Details
Roswell Park Comprehensive Cancer Center RECRUITING Buffalo New York 14263 United States Details
New York University Langone Hospital - Long Island Site# 153 RECRUITING Mineola New York 11501 United States Details
Weill Cornell Medical Center RECRUITING New York New York 10065 United States Details
Oregon Health and Science University RECRUITING Portland Oregon 97239 United States Details
Oregon Oncology Specialists RECRUITING Salem Oregon 97301 United States Details
Vanderbilt University Medical Center RECRUITING Nashville Tennessee 37232 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Seattle Cancer Care Alliance RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field